Searched for
OSIMERTINIB
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Stocks in news: Nykaa, Delhivery, IndusInd Bank, Mazagon Dock, ITCMarkets declined by nearly one and a half percent due to weak global cues. Key stocks such as Nykaa, Delhivery, IndusInd Bank, and ITC will...
- Union Budget 2025: Key healthcare moves for cancer treatment & more at total industry allocation of Rs 98,311 croreIn the Union Budget 2025-26, Finance Minister Nirmala Sitharaman announces Rs 98,311 crore allocation for healthcare, introducing daycare c...
- Budget 2025 for healthcare: Big changes in import duty for lifesaving medicinesFinance Minister Nirmala Sitharaman presented the Union Budget 2025, highlighting measures to enhance healthcare affordability. Key initiat...
- NPPA asks companies to cut prices of three cancer drugs post tax reliefIn a move aimed at providing relief to cancer patients, the National Pharmaceutical Pricing Authority (NPPA) has directed drug manufacturer...
- Govt asks manufacturers to cut price of 3 anti-cancer drugsThe government has directed manufacturers to lower prices of Trastuzumab, Osimertinib, and Durvalumab after exempting them from customs dut...
- GST Council spices things up: Here's what got cheaper overnight in IndiaGST Council Meeting decisions: The GST Council's meeting on Monday announced significant tax cuts to make essential goods and services more...
- Med in India: Quality, affordability, accessDrugs made locally, be it under patent or generic, must be of high and uniform quality. Variations in quality has dogged the domestic pharm...
- Budget 2024: Cancer patients get relief but senior citizens missed the attentionThe Union Budget 2024, while significantly increasing health sector funding to ₹90,959 crore, failed to address the BJP’s poll promise of i...
- Budget 2024 at a glance: What's going down and what's moving upShea butter cosmetics — customs duty on shea nuts reduced to 15% from 30%. Stretchable clothes that contain spandex, such as jeans and tops...
- Budget 2024: Some relief for cancer patients and increased PLI allocation for pharmaUnion Budget 2024 benefits pharma, healthcare by exempting AstraZeneca's cancer drugs Trastuzumab Deruxtecan, Osimertinib, Durvalumab, boos...
- Budget 2024 Decoded: Your 2 minute guide to become a budget proBudget Decoded: Finance Minister Nirmala announced a host of steps for the economy, companies, markets and taxpayers in the Budget 2024. He...
- Union health ministry allocated Rs 90,958.63 cr in 2024-25 budgetThe Union health ministry receives a budget increase to Rs 90,958.63 crore for 2024-25. Customs duty exemptions on three cancer drugs annou...
- Budget 2024: Government proposes to fully exempt 3 cancer drugs from customs dutyThe government proposes to cut custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to nil. Finance Ministe...
- AstraZeneca bets on licencing deals, public-private partnerships for India growthBritish-Swedish drugmaker AstraZeneca is set to launch 15 new products in India from 2023 to 2025, focusing on oncology, cardiovascular, re...
- Miracle pill can keep lung cancer at bay: ReportThe treatment developed by the pharmaceutical group AstraZeneca is called osimertinib and is marketed under the name Tagrisso.
- AstraZeneca working on vaccine to prevent and cure Covid: MD Gagandeep SinghAnglo-Swedish pharma company AstraZeneca has mobilised research efforts to advance the development of a novel coronavirus-neutralising long...
- AstraZeneca Pharma India moves Delhi High Court against NPPA demand noticeThe notice of demand alleges that the company has overcharged about Rs 157.38 crore during the period from March 8, 2019 to January 31, 202...
- Zydus Cadila gets tentative USFDA nod to market lung cancer treatment drugThe company has received tentative approval from the US Food and Drug Administration (USFDA) to market Osimertinib tablets in the strengths...
- Illegal cancer drugs from Bangladesh flood local marketIllegal import of drugs from Bangladesh and other neighbouring countries have further added to the woes of pharmaceutical companies. Expert...
Load More
